ArticleHuman vaccines & immunotherapeutics2024
Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab.
Tjalf Ziemssen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.